Could a wearable robot help people with amyotrophic lateral sclerosis (ALS) walk farther? A new study from Toho University in ...

Coya is currently conducting the ALSTARS Trial, a Phase 2/3, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ...

The ALS Association today launched We Are Undeniable, a national campaign to help people living with ALS fight insurance ...

After a physically and emotionally taxing 2025-26 season for Brandon Montour, he’s back strong with an “A” on his Kraken ...

From Baltimore to Antarctica to Miami, a Ravens staffer is taking on seven marathons in seven days for a cause close to his heart.

A new study by ALS Canada is highlighting how much the disease is costing Canadians, including patients and their families.

Development of quantitative biomarker strategies for proteopathies through seragy’s proprietary SeRAS® technologyExpansion of the company’s laboratory and analytical capabilities with funding from ...

Peter Boshyk and CEO of ALS Canada Tammy Moore on the financial impacts of the disease and the action that needs to be taken ...

Upper Austria is investing millions in new MRI machines. Nevertheless, patients in this region have to wait significantly ...

Kinshasa - In der Demokratischen Republik Kongo sind nach Angaben der Behörden bereits 9.144 Ebola-Fälle im Labor bestätigt ...

Noch nie zuvor hat sich das Ebola-Virus in so schnell ausgebreitet wie aktuell im Kongo. Schon über 9.000 Menschen haben sich ...